Skip to main content

allergy

NDC 51316-117 · CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED

Generic namemometasone furoate monohydrate
Dosage formSPRAY, METERED
RouteNASAL
Active ingredient(s)MOMETASONE FUROATE MONOHYDRATE
Strength50 ug/1
Pharmacologic classCorticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
Marketing categoryNDA

Packages

51316-117-11 — 1 BOTTLE, SPRAY in 1 PACKAGE (51316-117-11) / 60 SPRAY, METERED in 1 BOTTLE, SPRAY

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0113-1720 — mometasone furoate, 0363-2060 — mometasone furoate monohydrate, 0536-1381 — mometasone furoate, 11822-7099 — mometasone furoate monohydrate, 42507-182 — mometasone furoate monohydrate, 51316-172 — mometasone furoate, 58602-522 — MOMETASONE FUROATE, 59467-700 — olopatadine hydrochloride and mometasone furoate, 59651-402 — MOMETASONE FUROATE MONOHYDRATE, 68462-659 — olopatadine hydrochloride and mometasone furoate, 70000-0635 — mometasone furoate, 72288-610 — mometasone furoate monohydrate, 76162-134 — mometasone furoate monohydrate

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels